References
- Webb-Peploe M M, Oakley C M, Croxon R S, Goodwin J F. Cardibselective beta adrenergic blockade in hypertrophic obstructive cardiomyopathy. Postgrad Med J 1971; 47(Suppl)93–7
- Bell R, Barber P V, Bray C L, Beton D C. Incidence of thyroid disease in cases of hypertrophic cardiomyopathy. Br Heart J 1978; 40: 1306–9
- Elliott C M, Tajik A J, Giuliani E R, Gordon H. Idiopathic hypertrophic subaortic stenosis associated with cutaneous neurofibromatosis: report of a case. Am Heart J 1976; 92: 368–72
- Hewer R L. The heart in Friedreich's ataxia. Br Heart J 1969; 31: 5–14
- Polani P E, Moynahan E J. Progressive car-diomyopathic lentiginosis. Q J Med 1972; 41: 202–25
- Somerville J, Bonham-Carter R E. The heart in letiginosis. Br Heart J 1972; 34: 58–66
- Symons C, Richardson P J, Feizi O. Hypertrophic cardiomyopathy in hyperthyreoidism: a report of 3 cases. Thorax 1974; 29: 713–9
- Thoren C. Cardiomyopathia in Friedreich's ataxia. Acta Pediatr 1964; 54: 153
- Goodwin J F. The frontiers of cardiomyopathy. Br Heart J 1982; 48: 1–18
- Ikram H, Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet 1981; ii: 490–3
- Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979; i: 1374–6
- Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J 1980; 44: 117–38
- Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022–36
- Bristow M R, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982; 307: 205–11
- Richardsson P J. Technique of endomyocardial biopsy—including description of a new form of endomyocardial bioptome. Postgrad Med J 1975; 51: 282–5
- Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
- Lee J. Alternative approaches for quantifying aggregate and individual agreements between two methods for assessing dietary intakes. Am J Clin Nutr 1980; 33: 956–8
- Miller J, Freund J E. Probability and statistics for engineers, 2nd ed. Prentice Hall, New Jersey 1977
- Siegel S. Non parametric statistics. MacGraw-Hill, New York 1956
- Baumann G, Felix St B, Schrader J, et al. Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Res Exp Med (Berl) 1981; 179: 81–98
- Golf S, Jahnsen T, Attramadal F F, Frøysaker T, Hansson V. Catecholamine responsive adenylate cyclase in human myocardial preparations. Properties and optimalization of assay conditions. Scand J Clin Lab Invest 1984; 44: 317–27
- Bristow M R, Cubicciotti R, Ginsburg R, Stinson E B, Johnson C. Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol 1982; 21: 671–9
- Glaubiger G, Lefkowitz R J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun 1977; 78: 720–5
- Stadel J M, Nambi P, Lavin T N, Heald S L, Caron M G, Lefkowitz R J. Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase. J Biol Chem 1982; 257: 9242–5
- Stadel J M, Strulovici B, Nambi P, et al. Desensitization of the beta-adrenergic receptor of frog erythrocytes. J Biol Chem 1983; 258: 3032–8